Liansong Ye

Liansong Ye

Auto-generated profile, based on publicly available information

Liansong Ye

Department of Gastroenterology and Hepatology, Sichuan University West China Hospital, Chengdu, China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
LCLiuxiang Chen
Liuxiang Chen
LYLiansong Ye
Liansong Ye
BHBing Hu
Bing Hu
Colorectal cancer (CRC) is the third most commonly diagnosed cancer worldwide. Hereditary CRC syndromes account for approximately 5–10% of all CRC, with a lifetime risk of CRC that approaches 50–80% in the absence of endoscopic or surgical treatment. Hereditary CRC syndromes can be phenotypically divided into polyposis and non-polyposis syndrome, mainly according to the conditions of polyps. The typical representatives are familial adenomatous polyposis (FAP) and Lynch syndromes (LS), respectively. Over the past few decades, molecular genetics enhanced the discovery of cancer-predisposing genes and revolutionized the field of clinical oncology. Hereditary CRC syndromes have been a key part of this effort, with data showing that pathogenic variants are present in up to 10% of cases. Molecular phenotypes of tumors can not only help identify individuals with genetic susceptibility to CRC but also guide the precision prevention and treatment for the development of CRC. This review emphasizes the molecular basis and prevention strategies for hereditary CRC syndromes.

24 April 2019 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
LYLiansong Ye
Liansong Ye
XYXianglei Yuan
Xianglei Yuan
MPMaoyin Pang
Maoyin Pang
JBJohannes Bethge
Johannes Bethge
MEMark Ellrichmann
Mark Ellrichmann
BHBing Hu
Bing Hu
Background Colorectal endoscopic submucosal dissection (ESD) has always been challenging for endoscopists, but the procedure can be facilitated after adequate exposure of submucosal layer and cutting line. We developed a traction method based on gravity for facilitating colorectal ESD, referred as magnetic bead-assisted ESD (MBA-ESD). This study aimed to compare the safety and effectiveness of MBA-ESD and conventional ESD for treating large superficial colorectal tumors. Methods This retrospective study included consecutive patients with large (≥ 20 mm in their maximal diameter) superficial colorectal tumors who underwent MBA-ESD or conventional ESD at our endoscopy center between June 2017 to January 2018. Each patient in the MBA-ESD group was matched to a patient in the conventional ESD group using propensity scores. Results Thirteen patients in each group were matched for the analyses. The baseline characteristics were balanced after propensity matching. The incidence of overall complications was significantly lower in the matched MBA-ESD group (0% vs. 38.5%, P = 0.039), while similar rates of en bloc resection, R0 resection, curative resection, and tumor recurrence were noted. Although without statistic difference, dissection time and speed were improved when using MBA-ESD (33 min vs. 40 min, P = 0.111; and 21 mm2/min vs. 16 mm2/min, P = 0.143, respectively). Conclusions MBA-ESD is a feasible, safe, and effective method for treating large superficial colorectal tumors. Further large, prospective and controlled studies are needed to fully assess this method.

18 July 2019 in Surgical Endoscopy
Verified
Journal Article
Open access
PDF file
XYXiang-Lei Yuan
Xiang-Lei Yuan
LYLian-Song Ye
Lian-Song Ye
QLQin Liu
Qin Liu
CWChun-Cheng Wu
Chun-Cheng Wu
WLWei Liu
Wei Liu
BHBing Hu
Bing Hu
Background The risk factors of duodenal injury from distal migrated biliary plastic stents remain uncertain. The aim of this study was to determine the risk factors of distal migration and its related duodenal injury in patients who underwent placement of a single biliary plastic stent for biliary strictures. Methods We retrospectively reviewed all patients with biliary strictures who underwent endoscopic placement of a single biliary plastic stent from January 2006 to October 2017. Results Two hundred forty-eight patients with 402 endoscopic retrograde cholangiopancreatography procedures were included. The incidence of distal migration was 6.2%. The frequency of duodenal injury was 2.2% in all cases and 36% in cases with distal migration. Benign biliary strictures (BBS), length of the stent above the proximal end of the stricture (> 2 cm), and duration of stent retention (< 3 months) were independently associated with distal migration (p = 0.018, p = 0.009, and p = 0.016, respectively). Duodenal injury occurred more commonly in cases with larger angle (≥ 30°) between the distal end of the stent and the centerline of the patient’s body (p = 0.018) or in cases with stent retention < 3 months (p = 0.031). Conclusions The risk factors of distal migration are BBS and the length of the stent above the proximal end of the stricture. The risk factor of duodenal injury due to distal migration is large angle (≥ 30°) between the distal end of the stent and the centerline of the patient’s body. Distal migration and related duodenal injury are more likely to present during the early period after biliary stenting.

1 June 2019 in Medicine
Verified
Journal Article
Open access
XYXianglei Yuan
Xianglei Yuan
WLWei Liu
Wei Liu
LYLiansong Ye
Liansong Ye
MWMengjuan Wu
Mengjuan Wu
BHBing Hu
Bing Hu
Rationale: The management of complete obstruction of anastomosis following colorectal surgery is challenging. Some modified minimally invasive methods have been reported to be successfully implemented in some cases. In this case report, we present a case to share our experience. Patient concerns: A 64-year-old man underwent low anterior resection and single barrel ileostomy for rectal cancer 5 months ago. Completely obstructed anastomotic stenosis was found during colonoscopy. Diagnosis: Colonoscopy showed the anastomosis at 8 cm from the anal verge was completely obstructed. Interventions: A small incision was made by a needle knife, and then the stenosis was sequentially dilated by using a wire-guided balloon dilator. Outcomes: The luminal continuity was reestablished. The patient underwent successful ileostomy closure 2 months later. At 18-months follow-up, no restenosis of the anastomosis was observed during colonoscopy. Lessons: Endoscopic small incision with a needle knife along with balloon dilation could be an alternative method for patients with complete obstruction of anastomosis after colorectal resection. But this procedure should be performed with great caution in selected patients and performed only by highly experienced endoscopists.

9 October 2017 in Endoscopy
Verified
Journal Article
Closed access
PDF file
WLWei Liu
Wei Liu
LLLing Liu
Ling Liu
HCHong-Lin Chen
Hong-Lin Chen
HZHong-Ze Zeng
Hong-Ze Zeng
CWChun-Cheng Wu
Chun-Cheng Wu
BHBing Hu
Bing Hu
A 54-year-old woman sought clinical consultation because of a > 27-year history of dysphagia. She had an Eckardt score of 13 and was diagnosed with sigmoid-type achalasia (S2 type, type II) based on esophageal motility testing, upper endoscopy, barium esophagography, and clinical presentations. We investigated a technique of peroral endoscopic myotomy (POEM) performed directly without a submucosal tunnel for the treatment of achalasia, which we call open POEM (O-POEM). O-POEM was successfully performed with no procedure-related adverse events, resulting in a post O-POEM Eckardt score of 2 ([Fig. 1], [Video 1]). The procedure time for O-POEM was 25.0 minutes and the length of the myotomy was 8.0 cm. Prophylactic antibiotics were given intravenously 30 minutes before O-POEM, and a nasogastric tube placement was continued for 2 days postoperatively. A liquid diet was allowed at postoperative Day 3, and then this patient was fit for discharge. Video 1 Preoperative gastroscopy showing a dilated and tortuous esophageal lumen (S2 type) with a tightly closed cardia. A submucosal injection and mucosal incision were performed, followed by the selective myotomy of the circular muscle. After complete myotomy, smooth passage of the endoscope through the esophagogastric junction was possible with minimal resistance. A regular diet was allowed at postoperative Day 10 and her symptoms resolved completely during the follow-up of 1 month. A reduction of lower esophageal sphincter pressure and a timed barium esophagogram were observed during follow-up 1 month later. The follow-up endoscopy performed for the patient 1 month later revealed healing mucosa in the area of O-POEM. POEM has become an established modality for achalasia because of its high feasibility and efficacy. However, the POEM procedure is based on endoscopic myotomy using the submucosal tunnel as an operating space, which is highly demanding technically. Implementation of new technology in achalasia is a challenge for endoscopic treatment, especially when it comes to complex achalasia with a sigmoid-shaped esophagus (S2 type) [1] [2], because the dilated and tortuous esophageal lumen may make subsequent endoscopic dissection and separation of tissue planes difficult; thus, endoscopic treatment for advanced achalasia with sigmoid-type esophagus is still challenging. This O-POEM technique takes advantage of the POEM procedure to achieve selective myotomy of the circular muscle, and the remarkable capacity of the esophageal epithelial cells for tissue repair and wound healing [3] [4]. O-POEM is a feasible and effective endoscopic treatment modality for achalasia with sigmoid-shaped esophagus. The O-POEM procedure for the treatment of achalasia is easier and less time-consuming than POEM. The short-term outcome of O-POEM for achalasia with sigmoid-shaped esophagus is excellent, with short-term symptom relief in the current case without any complications. However, further randomized controlled clinical trials are needed to focus on the question of whether or not this technique has the potential to replace traditional POEM for achalasia with sigmoid-type esophagus. Endoscopy_UCTN_Code_TTT_1AQ_2AF * These authors contributed equally to this paper.

21 May 2019 in World Journal of Gastroenterology
Verified
Journal Article
Open access
XYXiang-Lei Yuan
Xiang-Lei Yuan
BWBin Wei
Bin Wei
LYLian-Song Ye
Lian-Song Ye
CWChun-Cheng Wu
Chun-Cheng Wu
QTQing-Hua Tan
Qing-Hua Tan
BHBing Hu
Bing Hu
Endoscopic biliary stenting is a well-established palliative treatment for patients with unresectable distal malignant biliary obstruction (MBO). However, the main problem with stent placement is the relatively short duration of stent patency. Although self-expanding metal stents (SEMSs) have a longer patency period than plastic stents (PSs), the higher costs limit the wide use of SEMSs. A PS with an antireflux valve is an attractive idea to prolong stent patency, but no ideal design for an antireflux PS (ARPS) has been proposed. We developed a new ARPS with a "duckbilled" valve attached to the duodenal end of the stent. To compare the patency of ARPSs with that of traditional PSs (TPSs) in patients with unresectable distal MBO. We conducted a single-center, prospective, randomized, controlled, double-blind study. This study was conducted at the West China Hospital of Sichuan University. Consecutive patients with extrahepatic MBO were enrolled prospectively. Eligible patients were randomly assigned to receive either an ARPS or a TPS. Patients were followed by clinic visits or telephone interviews every 1-2 mo until stent exchange, death, or the final study follow-up in October 2018. The primary outcome was the duration of stent patency. Secondary outcomes included the rate of technical success, the rate of clinical success, adverse events, and patient survival. Between February 2016 and December 2017, 38 patients were randomly assigned to two groups, with 19 patients in each group, to receive ARPSs or TPSs. Stent insertion was technically successful in all patients. There were no significant differences between the two groups in the rates of clinical success or the rates of early or late adverse events (P = 0.660, 1.000, and 1.000, respectively). The median duration of stent patency in the ARPS group was 285 d [interquartile range (IQR), 170], which was significantly longer than that in the TPS group (median, 130 d; IQR, 90, P = 0.005). No significant difference in patient survival was noted between the two groups (P = 0.900). The new ARPS is safe and effective for the palliation of unresectable distal MBO, and has a significantly longer stent patency than a TPS.